uniformity in the diagnostic categories entered would reduce the variance in survival between different trials : for example , trials in myelomatosis should exclude patients with monoclonal gammopathy of uncertain significance , non-progressive or indolent myeloma , extramedullary plasmacytoma , and plasma-cell leukaemia .
C0026764
myelomatosis
C0023484
plasma-cell leukaemia